Discovery of a novel BLT2 antagonist for the treatment of inflammatory airway diseases-Reference-Cited by-同舟云学术

Discovery of a novel BLT2 antagonist for the treatment of inflammatory airway diseases

Published:2023-12 Issue: Volume:261 Page:115864
ISSN:0223-5234
Container-title:European Journal of Medicinal Chemistry
language:en
Short-container-title:European Journal of Medicinal Chemistry

Author:

Park Hyejun,Harmalkar Dipesh S.,Wei Jun-Dong,Sun Seunghan,Kwon Jinsun,Lee Chang Hoon,Song Jae Geun,Park Jin-Mi,Lee Jae-Won,Ahn Kyung-Seop,Han Hyo-Kyung,Kim Jae-Hong,Lee Kyeong,Choi Yongseok^ORCID

Funder

Korea University

Korea Ministry of Science and ICT

Ministry of Trade, Industry and Energy

Ministry of Science, ICT and Future Planning

Ministry of Health and Welfare

National Research Foundation of Korea

Korea Drug Development Fund

Publisher

Elsevier BV

Subject

Organic Chemistry,Drug Discovery,Pharmacology,General Medicine

Reference29 articles.

1. Leukotriene B4;Crooks;Int. J. Biochem. Cell Biol.,1998

2. The role of leukotrienes in allergic diseases;Liu;Allergol. Int. : Off. J. Jpn. Soc. Allergol.,2015

3. BLT1 and BLT2: the leukotriene B(4) receptors;Tager;Prostaglandins Leukot. Essent. Fatty Acids,2003

4. Recent advances in clinical development of leukotriene B4 pathway drugs;Bhatt;Semin. Immunol.,2017

5. The role of the LTB4-BLT1 axis in health and disease;He;Pharmacol. Res.,2020

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Resolvin E1 and Inhibition of BLT2 Signaling Attenuate the Inflammatory Response and Improve One-Lung Ventilation-Induced Lung Injury;Immunological Investigations;2024-09-04

2. Leukotriene B4 (LTB4) Aggravates Myocardial Ischemia-Reperfusion Injury through BLT2/JAK1/STAT1 Pathway;J BIOL REG HOMEOS AG;2024